Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47415)
CDC/NIH Web Information Database (32174)
CDC-Authored Genomics and Precision Health Publications Database (5825)
Precision Health Database (63627)
Tier-Classified Guidelines Database (533)
Pathogen Advanced Molecular Detection Database (26729)
All of Us Reports and Publications Database (656)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226255)
Epigenetic Epidemiology Publications Database (22724)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Last data update: Apr 19, 2024
. (Total: 63627 Documents since 2012)
All
Cancer
Diabetes
Economic
Equity
Environmental
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 30 (of 108 Records)
Next
Query Trace:
Ovarian cancer[original query]>>Evidence Synthesis [Product Type]
Cost-Effectiveness of Population-Based Multigene Testing for Breast and Ovarian Cancer Prevention.
Fangjian Guo et al. JAMA Netw Open 2024 7(2) e2356078
Similar articles in PubMed
Preferences for Genetic Testing to Predict the Risk of Developing Hereditary Cancer: A Systematic Review of Discrete Choice Experiments.
N Morrish et al. Med Decis Making 2024 272989X241227425
Similar articles in PubMed
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer.
Xia Wei et al. JAMA Netw Open 2024 7(2) e2355324
Similar articles in PubMed
Prophylactic Interventions for Hereditary Breast and Ovarian Cancer Risks and Mortality in BRCA1/2 Carriers.
Taoran Liu et al. Cancers (Basel) 2024 16(1)
Similar articles in PubMed
Combined population genomic screening for three high-risk conditions in Australia: a modelling study.
Paul Lacaze et al. EClinicalMedicine 2024 66102297
Similar articles in PubMed
A cost-utility analysis of BRCA1 and BRCA2 testing in high-risk breast cancer patients and family members in Thailand: a cost-effective policy in resource-limited settings.
Pongtawat Lertwilaiwittaya et al. Front Public Health 2024 111257668
Similar articles in PubMed
Risk Factors for Developing Both Primary Breast and Primary Ovarian Cancer: A Systematic Review.
Jennifer S Ferris et al. Crit Rev Oncol Hematol 2023 104081
Similar articles in PubMed
Interventions to support decision making in people considering germline genetic testing for BRCA 1/2 pathogenic and likely pathogenic variants: A scoping review.
Rachel A Pozzar et al. J Genet Couns 2023
Similar articles in PubMed
Factors predicting BRCA1/2 pathogenic variants in patients with ovarian cancer: a systematic review with meta-analysis.
Giovanni Innella et al. J Clin Pathol 2023
Similar articles in PubMed
Circulating microRNAs for Early Diagnosis of Ovarian Cancer: A Systematic Review and Meta-Analysis.
Nanna Lond Skov Frisk et al. Biomolecules 2023 13(5)
Similar articles in PubMed
The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?
Vera M Witjes et al. Gynecol Oncol 2023 174121-128
Similar articles in PubMed
Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis.
Gregory F Guzauskas et al. Ann Intern Med 2023
Similar articles in PubMed
Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.
Luiza Perez et al. Gynecol Oncol 2023 173106-113
Similar articles in PubMed
Strong Cumulative Evidence of Associations of 6 Single Nucleotide Polymorphisms with Ovarian Cancer Risk: An Umbrella Review.
Ying-Jun Huo et al. Journal of clinical medicine 2023 12(5)
Similar articles in PubMed
Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis.
Cristina Mitric et al. Gynecologic oncology 2023 170133-142
Similar articles in PubMed
The expression and mutation of BRCA1/2 genes in ovarian cancer: a global systematic study.
Chu Dinh-Toi et al. Expert review of molecular diagnostics 2023
Similar articles in PubMed
Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies.
Michaelson-Cohen Rachel et al. Cancers 2022 14(24)
Similar articles in PubMed
Cost-Effectiveness of Risk-Reducing Surgery for Breast and Ovarian Cancer Prevention: A Systematic Review.
Wei Xia et al. Cancers 2022 14(24)
Similar articles in PubMed
Application of machine learning techniques for predicting survival in ovarian cancer.
Sorayaie Azar Amir et al. BMC medical informatics and decision making 2022 22(1) 345
Similar articles in PubMed
A review of the cost-effectiveness of genetic testing for germline variants in familial cancer.
Teppala Srinivas et al. Journal of medical economics 2022 1-38
Similar articles in PubMed
Systematic mapping review of guidelines for BRCA1/2 genetic testing globally: investigating geographic and regional disparities in health equity for women and families at risk for hereditary ovarian cancer.
Hughes Brittany N et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2022
Similar articles in PubMed
Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review.
Park Sun-Young et al. Korean journal of women health nursing 2022 26(4) 285-299
Similar articles in PubMed
Latinx attitudes, barriers, and experiences with genetic counseling and testing: A systematic review.
Dron Heather A et al. Journal of genetic counseling 2022
Similar articles in PubMed
Cost-Effectiveness Analysis of Germline and Somatic BRCA Testing in Patients With Advanced Ovarian Cancer.
Jang Jaehyeok et al. Annals of laboratory medicine 2022 43(1) 73-81
Similar articles in PubMed
Cost-Effectiveness of BRCA 1/2 Genetic Test and Preventive Strategies: Using Real-World Data From an Upper-Middle Income Country.
Lourenção Marina et al. Frontiers in oncology 2022 12951310
Similar articles in PubMed
Cost-Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Cancer Treatment: A Systematic Review.
Chan Vivien Kin Yi et al. Frontiers in pharmacology 2022 13891149
Similar articles in PubMed
The prevalence of mismatch repair deficiency in ovarian cancer: A systematic review and meta-analysis.
Atwal Amit et al. International journal of cancer 2022
Similar articles in PubMed
Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review.
Lim Natalie et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2022
Similar articles in PubMed
Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review.
Simões Corrêa Galendi Julia et al. Cancers 2022 14(7)
Similar articles in PubMed
Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China.
Sun Li et al. Cancers 2022 14(7)
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 19, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP